American Portfolios Advisors - GLOBAL BLOOD THERAPEUTICS IN ownership

GLOBAL BLOOD THERAPEUTICS IN's ticker is GBT and the CUSIP is 37890U108. A total of 239 filers reported holding GLOBAL BLOOD THERAPEUTICS IN in Q4 2019. The put-call ratio across all filers is 0.30 and the average weighting 0.3%.

Quarter-by-quarter ownership
American Portfolios Advisors ownership history of GLOBAL BLOOD THERAPEUTICS IN
ValueSharesWeighting
Q4 2020$2,166
-73.8%
50
-66.7%
0.00%
Q3 2020$8,271
+424.1%
150
+500.0%
0.00%
Q2 2020$1,578
+23.6%
250.0%0.00%
Q1 2020$1,277
-83.9%
25
-75.0%
0.00%
-100.0%
Q4 2019$7,949
-31.7%
100
-58.3%
0.00%0.0%
Q3 2019$11,645
-13.2%
240
-5.9%
0.00%0.0%
Q2 2019$13,413
+913.8%
255
+920.0%
0.00%
Q1 2019$1,323
-35.6%
25
-50.0%
0.00%
Q4 2018$2,053500.00%
Other shareholders
GLOBAL BLOOD THERAPEUTICS IN shareholders Q4 2019
NameSharesValueWeighting ↓
Logos Global Management LP 850,000$46,869,0006.00%
Asymmetry Capital Management, L.P. 155,232$8,559,0005.50%
Grace Capital 124,749$6,878,0005.33%
Fernwood Investment Management, LLC 187,477$10,337,0004.88%
Perceptive Advisors 5,800,996$319,867,0004.67%
ArchPoint Investors 217,510$11,993,0003.83%
GREAT POINT PARTNERS LLC 655,676$36,154,0003.25%
Profit Investment Management, LLC 42,196$2,328,0001.44%
Bain Capital Public Equity Management II, LLC 381,868$21,056,0001.39%
Taylor Wealth Management Partners 52,597$2,900,0001.33%
View complete list of GLOBAL BLOOD THERAPEUTICS IN shareholders